Product Wiki · Recalls · EU Safety Gate (RAPEX)

Eyelashserum Prime — recall SR/01833/26

EU Safety Gate (RAPEX) · Germany · 2026-06-26 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/01833/26
Date of alert
2026-06-26
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
Aphro Celina
Product category
Cosmetics
Product type
Eyelash serum
Barcode (EAN/GTIN)
4260294730007
🔴 Serious hazard — Reported risk: The product contains the active substance cloprostenol isopropyl ester (measured value: 4.5 mg/kg), which should be used under supervision of an ophthalmologist. Cloprostenol isopropyl ester is a prostaglandin analogue, which could cause eye and ophthalmic defects in the user and should not be used by pregnant and breastfeeding women, as it may affect the child.
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Manufacturer
Category of measure
Destruction of the product
Date of entry into force
03/06/2026
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10099350

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.